Scinai Immunotherapeutics (SCNI) Other Accumulated Expenses (2015 - 2026)
Scinai Immunotherapeutics (SCNI) recorded Other Accumulated Expenses of $1.02 million in Q2 2026, up 5.7% from $964,000 a year earlier but down 34.3% from the prior quarter.
Powered by 
Analysis
Scinai Immunotherapeutics (SCNI) Other Accumulated Expenses (2015 - 2026) Analysis & Trends
At the end of FY2025, Scinai Immunotherapeutics reported Other Accumulated Expenses of $849,000, down 15.6% from FY2024.
- Annual Other Accumulated Expenses has a five-year compound annual growth rate of -7.4% (FY2020 to FY2025).
- Across earlier years, Other Accumulated Expenses came in at $1.01 million in FY2024 (+18.5%), $849,000 in FY2023 (-31.5%), $1.24 million in FY2022 (+15.9%) and $1.07 million in FY2021 (-14.1%).
- Quarterly Other Accumulated Expenses has ranged from $524,000 in Q3 2021 to $1.55 million in Q1 2026 over the past five years.
- On a year-over-year basis, Other Accumulated Expenses rose in three of the last five quarters, with growth averaging 11.0%.
- Peak year-over-year performance for Other Accumulated Expenses in the last five years was growth of 55.5% in Q2 2023, against a decline of 68.8% in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn |
| 10 | Scinai Immunotherapeutics | 194,220.32 | -8.07 Mn | -1.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.55 Mn |
| Dec 31, 2025 | 849,000.00 |
| Jun 30, 2025 | 964,000.00 |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 598,000.00 |
| Jun 30, 2024 | 650,000.00 |
| Mar 31, 2024 | 610,000.00 |
| Dec 31, 2023 | 849,000.00 |
| Sep 30, 2023 | 610,000.00 |
| Jun 30, 2023 | 843,000.00 |
| Mar 31, 2023 | 846,000.00 |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 618,000.00 |
| Jun 30, 2022 | 542,000.00 |
| Mar 31, 2022 | 1.13 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 524,000.00 |
| Sep 30, 2020 | 665,000.00 |
| Dec 31, 2019 | 348,000.00 |
API Access
Scinai Immunotherapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SCNI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "SCNI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SCNI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();